SEI Investments’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Buy
40,117
+10,592
+36% +$3.35M 0.01% 987
2026
Q1
$9.51M Buy
29,525
+13,729
+87% +$4.25M 0.01% 1170
2025
Q4
$4.66M Buy
+15,796
New +$2.94M ﹤0.01% 1404
2025
Q1
Sell
-4,918
Closed -$378K 2823
2024
Q4
$378K Buy
4,918
+29
+0.6% +$2.1K ﹤0.01% 2278
2024
Q3
$281K Buy
+4,889
New +$264K ﹤0.01% 2376

Other funds holding PRAX

SEI Investments's PRAX Position: Q2 2026 in Review

SEI Investments increased its Praxis Precision Medicines (PRAX) stake by 36% in Q2 2026, buying an estimated $3.35M and bringing the position to 40,117 shares worth $13.4M. The position accounts for 0.01% of the portfolio, ranked #987.

SEI Investments first reported a position in PRAX in Q3 2024 and has held it in 5 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • SEI Investments held 40,117 shares of Praxis Precision Medicines worth $13.4M as of Q2 2026.
  • SEI Investments bought 10,592 Praxis Precision Medicines shares in Q2 2026, an estimated $3.35M.
  • Praxis Precision Medicines made up 0.01% of SEI Investments's portfolio in Q2 2026, its #987 holding.
  • SEI Investments first reported a position in Praxis Precision Medicines in Q3 2024 and has held it in 5 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.